CXC chemokine receptor 4 (CXCR4) is a receptor overexpressed in several tumor types and associated with tumor aggressiveness and risk of metastasis, resistance and recurrence. A novel PET ...

Final data analysis from the Dimerix collaboration with PARASOL reinforces the company’s proteinuria-based endpoints in its ...

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...

Plain-language summary: Hemostemix will officially apply for ethics approval to begin a new clinical trial testing its ACP-01 stem-cell therapy in people with severe chest pain (angina) who no longer ...

New research based on adults who were cured of HIV after stem cell transplants may offer hope to ultimately have a global impact on HIV care. A total of 10 individuals with HIV have been cured to date ...

The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to ...

Immune checkpoint inhibitors (ICI) have had a dramatic effect on cancer outcomes with their use increasing as indications expand. Despite impressive efficacy across a range of tumour types, their role ...